866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Cancer Vaccines Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 110 Pages

In this report, the EMEA Cancer Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Cancer Vaccines for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cancer Vaccines market competition by top manufacturers/players, with Cancer Vaccines sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Dendreon
GlaxoSmithKline
Merck
Sanofi
Amgen
Biothera
Isa Pharmaceuticals
Bristol-Myers Squibb
Bavarian Nordic
Antigen Express
Juvaris Biotherapeutics
Provectus Biopharmaceuticals
Aduro BioTech
Galena Biopharma
Northwest Biotherapeutics
Oxford BioMedica
Inovio Pharmaceuticals
Vaxon Biotech
Celldex Therapeutics
Prima BioMed

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Rophylactic Vaccines
Therapeutic Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Cancer Vaccines for each application, including
Adults
Children

If you have any special requirements, please let us know and we will offer you the report as you want.
 

Table of Contents

EMEA (Europe, Middle East and Africa) Cancer Vaccines Market Report 2017
1 Cancer Vaccines Overview
1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines
1.2.1 EMEA Cancer Vaccines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Cancer Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Rophylactic Vaccines
1.2.4 Therapeutic Vaccines
1.3 EMEA Cancer Vaccines Market by Application/End Users
1.3.1 EMEA Cancer Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Adults
1.3.3 Children
1.4 EMEA Cancer Vaccines Market by Region
1.4.1 EMEA Cancer Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Cancer Vaccines (2012-2022)
1.5.1 EMEA Cancer Vaccines Sales and Growth Rate (2012-2022)
1.5.2 EMEA Cancer Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA Cancer Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Cancer Vaccines Market Competition by Players/Manufacturers
2.1.1 EMEA Cancer Vaccines Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Cancer Vaccines Revenue and Share by Players (2012-2017)
2.1.3 EMEA Cancer Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Cancer Vaccines (Volume and Value) by Type/Product Category
2.2.1 EMEA Cancer Vaccines Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Cancer Vaccines Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Cancer Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Cancer Vaccines (Volume) by Application
2.4 EMEA Cancer Vaccines (Volume and Value) by Region
2.4.1 EMEA Cancer Vaccines Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Cancer Vaccines Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Cancer Vaccines Sales Price by Region (2012-2017)

3 Europe Cancer Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Cancer Vaccines Sales and Value (2012-2017)
3.1.1 Europe Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Cancer Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Cancer Vaccines Sales and Market Share by Type
3.3 Europe Cancer Vaccines Sales and Market Share by Application
3.4 Europe Cancer Vaccines Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Cancer Vaccines Sales Volume by Countries (2012-2017)
3.4.2 Europe Cancer Vaccines Revenue by Countries (2012-2017)
3.4.3 Germany Cancer Vaccines Sales and Growth Rate (2012-2017)
3.4.4 France Cancer Vaccines Sales and Growth Rate (2012-2017)
3.4.5 UK Cancer Vaccines Sales and Growth Rate (2012-2017)
3.4.6 Russia Cancer Vaccines Sales and Growth Rate (2012-2017)
3.4.7 Italy Cancer Vaccines Sales and Growth Rate (2012-2017)
3.4.8 Benelux Cancer Vaccines Sales and Growth Rate (2012-2017)

4 Middle East Cancer Vaccines (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Cancer Vaccines Sales and Value (2012-2017)
4.1.1 Middle East Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Cancer Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Cancer Vaccines Sales and Market Share by Type
4.3 Middle East Cancer Vaccines Sales and Market Share by Application
4.4 Middle East Cancer Vaccines Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Cancer Vaccines Sales Volume by Countries (2012-2017)
4.4.2 Middle East Cancer Vaccines Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Cancer Vaccines Sales and Growth Rate (2012-2017)
4.4.4 Israel Cancer Vaccines Sales and Growth Rate (2012-2017)
4.4.5 UAE Cancer Vaccines Sales and Growth Rate (2012-2017)
4.4.6 Iran Cancer Vaccines Sales and Growth Rate (2012-2017)

5 Africa Cancer Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Cancer Vaccines Sales and Value (2012-2017)
5.1.1 Africa Cancer Vaccines Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Cancer Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Cancer Vaccines Sales and Market Share by Type
5.3 Africa Cancer Vaccines Sales and Market Share by Application
5.4 Africa Cancer Vaccines Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Cancer Vaccines Sales Volume by Countries (2012-2017)
5.4.2 Africa Cancer Vaccines Revenue by Countries (2012-2017)
5.4.3 South Africa Cancer Vaccines Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Cancer Vaccines Sales and Growth Rate (2012-2017)
5.4.5 Egypt Cancer Vaccines Sales and Growth Rate (2012-2017)
5.4.6 Algeria Cancer Vaccines Sales and Growth Rate (2012-2017)

6 EMEA Cancer Vaccines Manufacturers/Players Profiles and Sales Data
6.1 Dendreon
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cancer Vaccines Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Cancer Vaccines Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Cancer Vaccines Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sanofi
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Cancer Vaccines Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Amgen
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Cancer Vaccines Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Amgen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Biothera
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Cancer Vaccines Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Biothera Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Isa Pharmaceuticals
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Cancer Vaccines Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Isa Pharmaceuticals Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Cancer Vaccines Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bristol-Myers Squibb Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Bavarian Nordic
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Cancer Vaccines Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Bavarian Nordic Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Antigen Express
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Cancer Vaccines Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Antigen Express Cancer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Juvaris Biotherapeutics
6.12 Provectus Biopharmaceuticals
6.13 Aduro BioTech
6.14 Galena Biopharma
6.15 Northwest Biotherapeutics
6.16 Oxford BioMedica
6.17 Inovio Pharmaceuticals
6.18 Vaxon Biotech
6.19 Celldex Therapeutics
6.20 Prima BioMed

7 Cancer Vaccines Manufacturing Cost Analysis
7.1 Cancer Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cancer Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Cancer Vaccines Market Forecast (2017-2022)
11.1 EMEA Cancer Vaccines Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Cancer Vaccines Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Cancer Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Cancer Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Cancer Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Cancer Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Cancer Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Cancer Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Cancer Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

 

List of Table

List of Tables and Figures

Figure Product Picture of Cancer Vaccines
Figure EMEA Cancer Vaccines Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Cancer Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Rophylactic Vaccines Product Picture
Figure Therapeutic Vaccines Product Picture
Figure EMEA Cancer Vaccines Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Cancer Vaccines by Application in 2016
Figure Adults Examples
Figure Children Examples
Figure EMEA Cancer Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Cancer Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Cancer Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Cancer Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Cancer Vaccines Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Cancer Vaccines Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Cancer Vaccines Sales Share by Players (2012-2017)
Figure 2016 Cancer Vaccines Sales Share by Players
Figure 2017 Cancer Vaccines Sales Share by Players
Figure EMEA Cancer Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Cancer Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Cancer Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Cancer Vaccines Revenue Share by Players
Table 2017 EMEA Cancer Vaccines Revenue Share by Players
Table EMEA Cancer Vaccines Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Cancer Vaccines Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Cancer Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Vaccines by Type (2012-2017)
Figure EMEA Cancer Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Cancer Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Cancer Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Type in 2016
Table EMEA Cancer Vaccines Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Cancer Vaccines Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Cancer Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Vaccines by Application (2012-2017)
Figure EMEA Cancer Vaccines Sales Market Share by Application in 2016
Table EMEA Cancer Vaccines Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Cancer Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Cancer Vaccines by Region (2012-2017)
Figure EMEA Cancer Vaccines Sales Market Share in 2016
Table EMEA Cancer Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Cancer Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Region (2012-2017)
Figure EMEA Cancer Vaccines Revenue Market Share Regions in 2016
Table EMEA Cancer Vaccines Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Cancer Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Cancer Vaccines Sales (K Pcs) by Type (2012-2017)
Table Europe Cancer Vaccines Market Share by Type (2012-2017)
Figure Europe Cancer Vaccines Market Share by Type in 2016
Table Europe Cancer Vaccines Sales (K Pcs) by Application (2012-2017)
Table Europe Cancer Vaccines Market Share by Application (2012-2017)
Figure Europe Cancer Vaccines Market Share by Application in 2016
Table Europe Cancer Vaccines Sales (K Pcs) by Countries (2012-2017)
Table Europe Cancer Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Cancer Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Cancer Vaccines Sales Market Share by Countries in 2016
Table Europe Cancer Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Cancer Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Cancer Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Cancer Vaccines Revenue Market Share by Countries in 2016
Figure Germany Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Cancer Vaccines Sales (K Pcs) by Type (2012-2017)
Table Middle East Cancer Vaccines Market Share by Type (2012-2017)
Figure Middle East Cancer Vaccines Market Share by Type (2012-2017)
Table Middle East Cancer Vaccines Sales (K Pcs) by Applications (2012-2017)
Table Middle East Cancer Vaccines Market Share by Applications (2012-2017)
Figure Middle East Cancer Vaccines Sales Market Share by Application in 2016
Table Middle East Cancer Vaccines Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Cancer Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Cancer Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Cancer Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Cancer Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Cancer Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Cancer Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Cancer Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Cancer Vaccines Sales (K Pcs) by Type (2012-2017)
Table Africa Cancer Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Cancer Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Cancer Vaccines Sales Market Share by Type in 2016
Table Africa Cancer Vaccines Sales (K Pcs) by Application (2012-2017)
Table Africa Cancer Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Cancer Vaccines Sales Market Share by Application (2012-2017)
Table Africa Cancer Vaccines Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Cancer Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Cancer Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Cancer Vaccines Sales Market Share by Countries in 2016
Table Africa Cancer Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Cancer Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Cancer Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Cancer Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Table Dendreon Cancer Vaccines Basic Information List
Table Dendreon Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dendreon Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dendreon Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Dendreon Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Cancer Vaccines Basic Information List
Table GlaxoSmithKline Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Merck Cancer Vaccines Basic Information List
Table Merck Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Merck Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Sanofi Cancer Vaccines Basic Information List
Table Sanofi Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Sanofi Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Amgen Cancer Vaccines Basic Information List
Table Amgen Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Amgen Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Biothera Cancer Vaccines Basic Information List
Table Biothera Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biothera Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biothera Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Biothera Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Isa Pharmaceuticals Cancer Vaccines Basic Information List
Table Isa Pharmaceuticals Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Isa Pharmaceuticals Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Cancer Vaccines Basic Information List
Table Bristol-Myers Squibb Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Bavarian Nordic Cancer Vaccines Basic Information List
Table Bavarian Nordic Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Bavarian Nordic Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Antigen Express Cancer Vaccines Basic Information List
Table Antigen Express Cancer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Antigen Express Cancer Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Antigen Express Cancer Vaccines Sales Market Share in EMEA (2012-2017)
Figure Antigen Express Cancer Vaccines Revenue Market Share in EMEA (2012-2017)
Table Juvaris Biotherapeutics Cancer Vaccines Basic Information List
Table Provectus Biopharmaceuticals Cancer Vaccines Basic Information List
Table Aduro BioTech Cancer Vaccines Basic Information List
Table Galena Biopharma Cancer Vaccines Basic Information List
Table Northwest Biotherapeutics Cancer Vaccines Basic Information List
Table Oxford BioMedica Cancer Vaccines Basic Information List
Table Inovio Pharmaceuticals Cancer Vaccines Basic Information List
Table Vaxon Biotech Cancer Vaccines Basic Information List
Table Celldex Therapeutics Cancer Vaccines Basic Information List
Table Prima BioMed Cancer Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure EMEA Cancer Vaccines Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Cancer Vaccines Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Cancer Vaccines Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Cancer Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Cancer Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Cancer Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Cancer Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Cancer Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Cancer Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Cancer Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Cancer Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Cancer Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Cancer Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Cancer Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Cancer Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Cancer Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Cancer Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Cancer Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Cancer Vaccines Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Cancer Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Cancer Vaccines Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Cancer Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *